# PoX ‚Äî Share Package for Allies ü§ù

**For: Well-connected, non-super-technical supporters**

---

## üìñ Reading Order (15 minutes total)

### 1. Start Here: **JUDGES.md** (5 min)
**What it is**: Non-technical pitch explaining the problem and solution

**Key takeaways**:
- $28B/year reproducibility crisis in science
- Current peer review is unpaid labor (no incentive to find errors)
- PoX rewards scientists with blockchain reputation for validated experiments
- Type-specific multipliers (PXRD 3√ó, NMR 2√ó, HPLC 1√ó) align incentives with error rates

**Read this if**: You want to understand "what is PoX and why does it matter"

---

### 2. Deep Dive: **PEER_REVIEW_ROADMAP.md** (8 min)
**What it is**: Vision document with real-world impact analysis

**Key takeaways**:
- Different experiments have different error rates (PXRD >50%, NMR 30-40%, HPLC 5-10%)
- Economic model: $5.50/hour for NMR reviews (better than $0 for traditional peer review)
- Use cases: Pharma QC, natural products chemistry, metabolomics
- Journal partnership strategy (target: *Journal of Organic Chemistry*)
- 4-phase roadmap from MVP ‚Üí production

**Read this if**: You want to pitch PoX to potential partners (journals, labs, funders)

**Forward to**: 
- University researchers (chemistry, materials science)
- Journal editors (especially analytical chemistry journals)
- DeSci investors (VitaDAO, Protocol Labs, Ethereum Foundation)
- Pharma contacts (QC departments care about PXRD validation)

---

### 3. Quick Reference: **DEMO_CHEATSHEET.md** (2 min)
**What it is**: 1-page talking points for when you're pitching PoX

**Key takeaways**:
- 30-second elevator pitch (memorize this!)
- Key numbers: 25 experiments on-chain, 3√ó multiplier for PXRD
- One-liners: "Peer review, not fraud proof" / "$5.50/hour beats $0/hour"
- Common objections + answers

**Read this if**: You're introducing PoX to someone at a conference/meeting

**Perfect for**: Quick reference before a call or meeting

---

## üéØ Elevator Pitch (Copy-Paste Ready)

> "PoX is type-specific peer review for science. Different experiments have different error rates‚ÄîPXRD 50%, NMR 30%, HPLC 5%‚Äîso we built reputation multipliers that reward reviewers proportionally. Find a PXRD error? Earn 3√ó reputation. This aligns economic incentives with scientific value. Think of it as 'proof-of-stake for science'‚Äîyour reputation is at stake, and you earn more for finding harder errors."

---

## üí° Why This Matters (For Your Network)

### For **Academic Researchers**:
"Build on-chain reputation that follows you between institutions. 'Show me your PoX score' becomes the new 'Show me your h-index'."

### For **Journal Editors**:
"Require PoX CIDs in supporting information. First blockchain-verified journal. Reduce retractions, speed up peer review."

### For **Pharma QC**:
"PXRD validation with 3√ó reputation multiplier attracts expert reviewers. Catch polymorph errors before clinical trials. Save millions."

### For **DeSci Investors**:
"$28B/year problem. Proven traction (25 experiments on-chain). Clear go-to-market (target PXRD first‚Äîhighest error rate, biggest pain point). Team has domain expertise + execution speed (built V2 in 72 minutes)."

---

## üìä Key Stats (Memorize These)

- **Problem Size**: $28B/year reproducibility crisis
- **Error Rates**: PXRD 50% > NMR 30% > HPLC 5%
- **Multipliers**: PXRD 3√ó > NMR 2√ó > HPLC 1√ó
- **Economics**: $5.50/hour for NMR reviews (vs. $0 traditional)
- **Traction**: 25 experiments on-chain, live dashboard
- **Network**: Filecoin Calibration testnet, mainnet next week

---

## üîó Who to Connect Us With

### **High Priority**:
1. **Journal editors** at *J. Org. Chem.*, *Acta Cryst.*, *J. Proteome Res.*
2. **Protocol Labs** (Filecoin partnership)
3. **DeSci DAOs**: VitaDAO, ValleyDAO, LabDAO
4. **Pharma QC directors** (especially polymorph specialists)
5. **University analytical chemistry core facilities**

### **Medium Priority**:
6. **NSF program officers** (especially SBIR/STTR)
7. **ACS Division of Analytical Chemistry** leaders
8. **Causality Network** (lab instrument integration)
9. **Crystallography community** (PXRD is our killer use case)

### **Warm Intro Template**:
> "Hey [Name], wanted to introduce you to [Your Name] who's building PoX‚Äîblockchain reputation for scientific peer review. They've already got 25 experiments on-chain and are targeting PXRD validation (50% error rate!) as their wedge. Thought you two should connect given your work in [domain]. [Your Name], [Name] is [description]. [Name], here's their pitch doc: [link to JUDGES.md]."

---

## ‚ùì FAQs (For When Your Contacts Ask)

**Q: "Is this just crypto hype?"**  
A: "No. Real scientists, real data, real problem. 25 experiments already on-chain. Dashboard is live. No tokens, just reputation."

**Q: "Why would scientists trust blockchain?"**  
A: "They already trust DOIs (also cryptographic hashes). We use scientific terminology ('peer review' not 'fraud proof'). Adoption over purity."

**Q: "What's the business model?"**  
A: "Phase 1: Grants. Phase 2: Marketplace fees (3%). Phase 3: Lab subscriptions ($500/mo enterprise). Public goods layer stays free."

**Q: "How is this different from [ResearchGate/Academia.edu/etc]?"**  
A: "Those are paper-sharing. PoX is data validation with economic incentives. We cryptographically verify experiments, not just host PDFs."

**Q: "Can I try it?"**  
A: "Yes! Testnet live now. Mainnet launches Week 1 post-hackathon. Email [your-email] for early access."

---

## üìß Copy-Paste Intro Email

```
Subject: PoX ‚Äî Type-Specific Peer Review for Science

Hi [Name],

Quick intro: PoX is blockchain-based reputation for scientific peer review, 
with type-specific multipliers that reward harder problems more.

Key insight: PXRD has 50% error rate, HPLC has 5%. We pay reviewers 3√ó 
reputation for PXRD, 1√ó for HPLC. This aligns incentives with reality.

Why it matters:
- $28B/year reproducibility crisis
- Current peer review is unpaid (no incentive to find errors)
- First system that rewards reviewers proportionally to difficulty

Traction:
- 25 experiments on-chain (live testnet)
- Working dashboard: [demo link]
- Targeting pharma QC + crystallography first

Ask: [Specific request based on their role]
- Journals: Pilot program requiring PoX CIDs
- Funders: Grant partnership discussion
- Labs: Beta testing + feedback

Full pitch: [attach JUDGES.md]
Roadmap: [attach PEER_REVIEW_ROADMAP.md]

Happy to jump on a call if this resonates.

Best,
[Your Name]

P.S. Built the V2 system in 72 minutes at 3 AM during ETH Global Buenos 
Aires. Production-ready, not vaporware. üöÄ
```

---

## üé¨ What to Show (If Demo Opportunity)

1. **Live Dashboard**: http://localhost:3000/experiments (or deployed URL)
2. **Multipliers Table**: Show PXRD 3√ó > NMR 2√ó > HPLC 1√ó
3. **Smart Contracts**: On Arbiscan/Filscan (cryptographic proof)
4. **Roadmap**: Phase 1 done, Phase 2 next (credibility)

**Demo Flow**: Problem (30s) ‚Üí Solution (30s) ‚Üí Live Demo (2 min) ‚Üí Ask (30s)

---

## ‚úÖ Next Steps for Allies

After reading these docs, you can help by:

1. **Share with your network**: Researchers, journal editors, funders
2. **Make warm intros**: See "Who to Connect Us With" above
3. **Provide feedback**: What resonates? What's confusing?
4. **Beta test**: Upload an experiment, try peer review flow
5. **Amplify**: Tweet, blog, mention in talks (if appropriate)

---

## üì± Stay in Touch

- **Project**: PoX (Proof-of-Experiment)
- **GitHub**: [repo link]
- **Dashboard**: [live link]
- **Email**: [your-email]
- **Twitter**: [handle] (if you have one)

**Built at**: ETH Global Buenos Aires, Nov 2025  
**Motto**: *Fortis est Veritas* (Truth is strong)

---

**Thanks for supporting PoX!** üôè

*Your connections and advocacy are invaluable. Together we can fix the reproducibility crisis.*
```

---

**TL;DR for You**: 
Give them **JUDGES.md** first. If they're excited, send **PEER_REVIEW_ROADMAP.md**. If they're pitching for you, send **DEMO_CHEATSHEET.md** too.

**Bonus**: Send this file (**SHARE_WITH_ALLIES.md**) as a cover letter explaining what each doc is for.
